Maui Derm

Other Key Congresses - 2025

January 25-29, 2026, Grand Wailea, Maui, Hawaii
Poster icon

Remibrutinib improves urticaria symptoms, quality of life, and sleep: An analysis from REMIX-1/-2 studies

Mark Lebwohl, Vipul Jain, Michihiro Hide, Hao Cheng, Petra Staubach-Renz, Sibylle Haemmerle, Christine Elke Ortmann, El-Djouher Martzloff, Karine Lheritier, Hugh Windom
Poster icon

Early and sustained efficacy of remibrutinib in adult patients with CSU: Pooled analysis of REMIX-1/-2 studies

Shaila Gogate, Michael Palumbo, Ana Maria Giménez-Arnau, Shiqin Tao, Michihiro Hide, Karine Lheritier, Paula Machado, Knut Brockow
Poster icon

Concomitant use of antiplatelet agents with remibrutinib in the Phase 3 REMIX-1/-2 studies

Lindsey Finklea, Michael Palumbo, Alis Burciu, Sibylle Haemmerle
January 20-24, 2025, Maui, Hawaii
Poster icon

Pooled REMIX-1/-2 phase 3 data: Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria

S. Saini, G. Mosnaim, A.G-Arnau, L. Li, El-D. Martzloff, A. Burciu, K. Lheritier, M. Metz

Poster icon

Out-of-pocket expenses in patients with chronic spontaneous urticaria: Results from Urticaria Voices

T.A. Winders, J.A. Bernstein, T. Raftery, N.C-Rothe, J. McCarthy, P. Saraswat, P. Orfanos, R.K. Kohli, D. Patil, K. Weller
Poster icon

Effect of remibrutinib on sleep and daily activities in patients with chronic spontaneous urticaria (CSU) up to week 52 in the REMIX-1/-2 studies

R. Snyder, Y. Bin, D. Merritt, S.F. Thomsen, A. Fukunaga, C. Field, S. Haemmerle, C-Ya. Chu, N. Seko, M. Metz
Poster icon

Improvements in itch and hive symptoms with remibrutinib as early as week 1 in patients with chronic spontaneous urticaria (CSU) in REMIX-1/-2

M. Scarupa, S. Dinehart, X. Jiang, L. Finklea, J. Reed, Y.M. Ye, C. Field, S. Haemmerle, P. Wang, G. Sussman
Poster icon

Effects of remibrutinib treatment on ambulatory blood pressure in adult patients with chronic spontaneous urticaria (CSU)

M. Palumbo, G. Mosnaim, U. Lippert, S. Haemmerle, M.F. Eigenmann, K. Lheritier, A. Zharkov, P. Machado, I. Rodriguez, M.G. Lebwohl
© Copyright 2026 Novartis Pharma AG